Selective inhibition of eukaryotic translation initiation factor 2α dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic β-cell dysfunction and apoptosis

被引:263
作者
Cnop, Miriam
Ladriere, Laurence
Hekerman, Paul
Ortis, Fernanda
Cardozo, Alessandra K.
Dogusan, Zeynep
Flamez, Daisy
Boyce, Michael
Yuan, Junying
Eizirik, Decio L.
机构
[1] Free Univ Brussels, Erasmus Sch Med, Expt Med Lab, B-1070 Brussels, Belgium
[2] Erasme Univ Hosp, Div Endocrinol, B-1070 Brussels, Belgium
[3] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.M607627200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Free fatty acids cause pancreatic beta-cell apoptosis and may contribute to beta-cell loss in type 2 diabetes via the induction of endoplasmic reticulum stress. Reductions in eukaryotic translation initiation factor (eIF) 2 alpha phosphorylation trigger P-cell failure and diabetes. Salubrinal selectively inhibits eIF2 alpha dephosphorylation, protects other cells against endoplasmic reticulum stress-mediated apoptosis, and has been proposed as a beta-cell protector. Unexpectedly, salubrinal induced apoptosis in primary beta-cells, and it potentiated the deleterious effects of oleate and palmitate. Salubrinal induced a marked eIF2 alpha phosphorylation and potentiated the inhibitory effects of free fatty acids on protein synthesis and insulin release. The synergistic activation of the PERK-eIF2 alpha branch of the endoplasmic reticulum stress response, but not of the IRE1 and activating transcription factor-6 pathways, led to a marked induction of activating transcription factor-4 and the pro-apoptotic transcription factor CHOP. Our findings demonstrate that excessive eIF2 alpha phosphorylation is poorly tolerated by beta-cells and exacerbates free fatty acid-induced apoptosis. This modifies the present paradigm regarding the beneficial role of eIF2 alpha phosphorylation in beta-cells and must be taken into consideration when designing therapies to protect beta-cells in type 2 diabetes.
引用
收藏
页码:3989 / 3997
页数:9
相关论文
共 58 条
  • [1] ESTABLISHMENT OF 2-MERCAPTOETHANOL-DEPENDENT DIFFERENTIATED INSULIN-SECRETING CELL-LINES
    ASFARI, M
    JANJIC, D
    MEDA, P
    LI, GD
    HALBAN, PA
    WOLLHEIM, CB
    [J]. ENDOCRINOLOGY, 1992, 130 (01) : 167 - 178
  • [2] Cellular response to endoplasmic reticulum stress: a matter of life or death
    Boyce, M
    Yuan, J
    [J]. CELL DEATH AND DIFFERENTIATION, 2006, 13 (03) : 363 - 373
  • [3] A selective inhibitor-of eIF2α dephosphorylation protects cells from ER stress
    Boyce, M
    Bryant, KF
    Jousse, C
    Long, K
    Harding, HP
    Scheuner, D
    Kaufman, RJ
    Ma, DW
    Coen, DM
    Ron, D
    Yuan, JY
    [J]. SCIENCE, 2005, 307 (5711) : 935 - 939
  • [4] β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes
    Butler, AE
    Janson, J
    Bonner-Weir, S
    Ritzel, R
    Rizza, RA
    Butler, PC
    [J]. DIABETES, 2003, 52 (01) : 102 - 110
  • [5] Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic β-cells
    Cardozo, AK
    Ortis, F
    Storling, J
    Feng, YM
    Rasschaert, J
    Tonnesen, M
    Van Eylen, F
    Mandrup-Poulsen, T
    Herchuez, A
    Eizirik, DL
    [J]. DIABETES, 2005, 54 (02) : 452 - 461
  • [6] Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1β-exposed human and rat islet cells
    Chen, MC
    Proost, P
    Gysemans, C
    Mathieu, C
    Eizirik, DL
    [J]. DIABETOLOGIA, 2001, 44 (03) : 325 - 332
  • [7] Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes -: Many differences, few similarities
    Cnop, M
    Welsh, N
    Jonas, JC
    Jörns, A
    Lenzen, S
    Eizirik, DL
    [J]. DIABETES, 2005, 54 : S97 - S107
  • [8] Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation
    Cnop, M
    Hannaert, JC
    Hoorens, A
    Eizirik, DL
    Pipeleers, DG
    [J]. DIABETES, 2001, 50 (08) : 1771 - 1777
  • [9] Troglitazone does not protect rat pancreatic β cells against free fatty acid-induced cytotoxicity
    Cnop, M
    Hannaert, JC
    Pipeleers, DG
    [J]. BIOCHEMICAL PHARMACOLOGY, 2002, 63 (07) : 1281 - 1285
  • [10] Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells
    Darville, MI
    Eizirik, DL
    [J]. DIABETOLOGIA, 1998, 41 (09) : 1101 - 1108